Practice/Industry Group Overview
When a group of the nation's most respected patent litigators came to Loeb & Loeb in February 2007 to join a firm already recognized nationally for its cutting edge intellectual property and high-tech savvy corporate practice, the vision behind the move was simple -- to build a practice that would address the full spectrum of legal issues facing companies in the scientific and health care fields through an interdisciplinary, and client-centric creative approach.
With the addition of a robust patent practice steeped with knowledge and experience in life sciences, medical devices and pharmaceuticals, we are ideally positioned to provide a wide range of services that reflect our understanding of the complex issues facing these companies. A fresh, flexible approach to client matters is delivered by attorneys who are committed to sharing knowledge, expertise and value. Many of our attorneys have educational and professional backgrounds in both law and scientific disciplines. Every matter for every client is handled by attorneys with the creativity and progressive, proactive approach that has long been a Loeb & Loeb hallmark, a hallmark shared with our new patent litigation colleagues.
Our capabilities include:
- Development agreements
- Financing and capitalization including SPACs, IPOs, PIPES, venture capital and private equity transactions
- Government and regulatory affairs including FDA, ITC, consumer protection regulations and Hatch-Waxman
- IP strategic counseling, including patent, trademarks, copyrights, unfair trade practices
- IP litigation, including patents, trademarks and copyrights
- Product liability and false claims matters
- Licensing, transfer and distribution agreements
- Marketing and advertising counseling and litigation
- Mergers and acquisitions
- Trans-national joint ventures
Our attorneys also work with their colleagues throughout the firm, counseling clients on matters including antitrust, bankruptcy, restructuring and creditors' rights, corporate compliance and investigations, employment and labor, securities litigation and white collar criminal defense.
Clients and Industries
We represent a wide range of clients -- from start-ups to multi-national corporations -with interests and facilities around the world. Because of Loeb's breadth, we are ideally positioned to represent clients' interest in cross-industry partnerships and matters that represent converging technologies formerly relegated to industry-exclusive sectors.
Our clients include public and private sector enterprises, as well as government entities involved in:
- Consumer products
- Clinical and hospital services
- Cosmetic and dental procedures
- Medical instrumentation
- Orthopedic devices
We assist our clients in virtually every stage of cutting-edge product development - research, trials, testing, manufacturing, delivery and product life-cycle extension. Firm clients include those involved in the development of ultrasonic dental probes, needle-less injection systems, groundbreaking pharmaceutical introductions and life-enhancing prosthetic devices.
For example, members of the Life Sciences, Medical Devices and Pharmaceuticals team are experienced with interpreting and applying the Hatch-Waxman Act including litigating infringement, validity and enforceability of patents on behalf of generic and branded pharmaceutical companies and developing legal strategies for their products.
Loeb & Loeb attorneys are equally at ease working with new companies on new product introductions as they are helping protect the hard-earned market positions of some of the best known global corporations. Our service approach combines sophisticated legal knowledge with strategic, forward-thinking counsel. The result fosters multi-faceted client relationships extending across industry lines to meet the challenges and complexities that those in the life sciences fields face today. The Loeb & Loeb approach is best described by our client as collaborative, creative and client-focused.
Our experience in a broad cross-section of industries and legal issues leads to the seamless integration of that knowledge with out-of-the-box, innovative solutions. The result is a value-added, client-centric approach to every matter the firm handles include the life-sciences.
Ira A. Schreger
Mark E. Waddell